Skip to main content
Premium Trial:

Request an Annual Quote

Life After NIH

Elias Zerhouni, the head of NIH during the Bush administration, is taking on a new role. He will be heading up global R&D at Sanofi-Aventis, reports Fierce Biotech. Zerhouni is replacing Marc Cluzel who resigned. Since leaving NIH, Zerhouni has consulted for Sanofi-Aventis, served on the boards of the Mayo Clinic and the Lasker Foundation, and worked at the Bill and Melinda Gates Foundation and Johns Hopkins University, adds Nature's The Great Beyond blog. "I have had the privilege of working with Elias for a long time. Through his vast experience and visionary approach, he has provided excellent advice and insight and has been central in implementing what is now one of the most promising R&D models in healthcare," says Sanofi-Aventis CEO Christopher Viehbacher in a statement.

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.